Based in East Lansing, MI, Retia Medical develops monitors specifically designed for high-risk patients, with their first product focusing on monitoring cardiac output. This technology, licensed from MSU and validated through extensive tests, accurately measures the flow rate of blood pumped by the heart. Initially targeting the ICU and operating rooms, the potential applications extend to emergency rooms and even home use. With the backing of the Pritzker/Vlock family office and a strong advisory board, Retia aims to obtain FDA approval and launch this groundbreaking product, improving the care of our most vulnerable patients.